Your Double Chin could disappear with just a simple injection
The cosmetic world is booming and in each new year, newer injections are being released. Most of today’s markets of injections, such as Botox, target wrinkles, lines, and folds of the face.
A new trend is about to surface… and that is ATX-101. This is a new injectable that specifically targets fat cells in the neck, thereby helping eliminate the double chin (currently in the process of gaining FDA approval).
Excess fat on the neck can be part of the normal aging process, genetics, or weight gain. Until recent developments, liposuction or direct surgical removal were the only options to get rid of fat. Fat freezing or superficial ultrasound treatments such as Ultherapy are used today as non-invasive alternatives. ATX-101 is the future of these techniques because it directly targets and eliminates the neck’s fat pad, thus reducing the double chin.
“Similarly to other nonsurgical facelift options, ATX-101 is most ideal for patients with a mild double chin,” says Dr. Payman Simoni, a Beverly Hills facial plastic surgeon. Since ATX-101 does not address loose skin or neck muscles, the best candidate for it would be a younger individual with good neck elasticity. It does not replace a surgical lift but is an excellent alternative for those seeking a non-invasive approach.
The full treatment consists of a series of two to four injections done about once a month. The price for this innovative new treatment is approximately the same as other alternative nonsurgical techniques, which range between $2,000-$3000. Since this will be the first time the FDA approves an injection specifically targeting and eliminating fat, ATX-101 is going to set a new trend in plastic surgery.